van den Boom N A C, van den Hurk A A, Evers S M A A, Poeze M
Maastricht University Medical Centre, Dept. of Trauma Surgery, P. Debyelaan 25, 6229, HX Maastricht, The Netherlands; Maastricht University, Care and Public Health Research Institute (CAPHRI), Universiteitssingel 40, 6229 ER Maastricht, The Netherlands; Nutrim School for Nutrition, Toxicology and Metabolism, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands.
Maastricht University, Faculty of Health, Medicine, and Life Sciences (FHML), Universiteitssingel 40, 6229 ER Maastricht, The Netherlands.
Injury. 2023 Oct;54(10):110913. doi: 10.1016/j.injury.2023.110913. Epub 2023 Jun 25.
The incidence of Lisfranc fractures is rising, along with the incidence of foot fractures in general. These injuries can lead to long-term healthcare use and societal costs. Current economic evaluation studies are scarce in Lisfranc fracture research, and only investigate the healthcare costs. The aim of the present study was to accurately measure the monetary societal burden of disease and quality of life in the first 6 months after the injury in patients with Lisfranc fractures in the Netherlands.
This study used a prevalence-based, bottom-up approach. Patients were included through thirteen medical centres in the Netherlands. Both stable and unstable injuries were included. The societal perspective was used. The costs were measured at baseline, 12 weeks and 6 months using the iMTA MCQ and PCQ questionnaires. Reference prices were used for valuation. Quality-of-life was measured using the EQ-5D-5 L and VAS scores.
214 patients were included. The mean age was 45.9 years, and 24.3% of patients had comorbidities. The baseline questionnaires yielded approximately €2023 as the total societal costs in the 3 months prior to injury. The follow-up questionnaires and surgery costs assessment yielded approximately €17,083 as the total costs in the first 6 months after injury. Of these costs, approximately two thirds could be attributed to productivity losses. The EQ-5D-5 L found a mean index value of 0.449 at baseline and an index value of 0.737 at the 6-month follow-up.
The total monetary societal costs in the first 6 months after injury are approximately €17,083. Approximately two thirds of these costs can be attributed to productivity losses. These costs appear to be somewhat higher than those found in other studies. However, these studies only included the healthcare costs. Furthermore, the baseline costs indicate relatively low healthcare usage before the injury compared to the average Dutch patient. The mean QoL index was 0.462 at baseline and 0.737 at 6 months, indicating a rise in QoL after treatment as well as a long-lasting impact on QoL. To our knowledge, this is only the first study investigating the societal costs of Lisfranc injuries, so more research is needed.
随着足部骨折总体发病率的上升，Lisfranc骨折的发病率也在上升。这些损伤会导致长期的医疗保健使用和社会成本。目前在Lisfranc骨折研究中经济评估研究较少，且仅调查了医疗保健成本。本研究的目的是准确衡量荷兰Lisfranc骨折患者受伤后前6个月的货币社会疾病负担和生活质量。
本研究采用基于患病率的自下而上的方法。通过荷兰的13个医疗中心纳入患者。纳入了稳定和不稳定损伤。采用社会视角。使用iMTA MCQ和PCQ问卷在基线、12周和6个月时测量成本。使用参考价格进行估值。使用EQ-5D-5L和VAS评分测量生活质量。
纳入214例患者。平均年龄为45.9岁，24.3%的患者有合并症。基线问卷得出受伤前3个月的社会总成本约为2023欧元。随访问卷和手术成本评估得出受伤后前6个月的总成本约为17083欧元。在这些成本中，约三分之二可归因于生产力损失。EQ-5D-5L在基线时的平均指数值为0.449，在6个月随访时的指数值为0.737。
受伤后前6个月的社会货币总成本约为17083欧元。这些成本中约三分之二可归因于生产力损失。这些成本似乎略高于其他研究中的成本。然而，这些研究仅包括医疗保健成本。此外，基线成本表明与荷兰普通患者相比，受伤前的医疗保健使用相对较低。平均生活质量指数在基线时为0.462，在6个月时为0.737，表明治疗后生活质量有所提高，且对生活质量有持久影响。据我们所知，这是第一项调查Lisfranc损伤社会成本的研究，因此需要更多的研究。
